The trading price of Mustang Bio Inc (NASDAQ:MBIO) closed lower on Friday, July 12, closing at $0.40, -4.66% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $5.77 and a 52-week low of $0.13. Over the past month, the stock has gained 169.62% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mustang Bio Inc, whose market valuation is $14.02 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest MBIO has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that MBIO’s price is currently -14.36% off the SMA20 and 20.96% off the SMA50. The RSI metric on the 14-day chart is currently showing 48.26, and weekly volatility stands at 10.08%. When measured over the past 30 days, the indicator reaches 31.82%. Mustang Bio Inc (NASDAQ:MBIO)’s beta value is currently sitting at 1.88, while the Average True Range indicator is currently displaying 0.10.
To see how Mustang Bio Inc stock has been performing in comparison to its peers in the industry, here are the numbers: MBIO stock’s performance was -4.66% in the latest trading, and -92.82% in the past year.
An evaluation of the daily trading volume of Mustang Bio Inc (NASDAQ:MBIO) indicates that the 3-month average is 29.56 million.
Currently, records show that 34.94 million of the company’s shares remain outstanding. The insiders hold 10.25% of outstanding shares, whereas institutions hold 2.54%. However, since the stock’s price has seen -70.28% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
